Kappa opioid agonists reduce oxycodone self-administration in male rhesus monkeys
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Kappa opioid agonists reduce oxycodone self-administration in male rhesus monkeys
Authors
Keywords
-
Journal
PSYCHOPHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-31
DOI
10.1007/s00213-020-05473-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of RGS12 in the differential regulation of kappa opioid receptor-dependent signaling and behavior
- (2019) Joshua D. Gross et al. NEUROPSYCHOPHARMACOLOGY
- A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
- (2019) Kendall L. Mores et al. Frontiers in Pharmacology
- Preclinical testing of nalfurafine as an opioid-sparing adjuvant that potentiates analgesia by the mu opioid receptor-targeting agonist morphine
- (2019) Shane W Kaski et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Punishment and reinforcement by opioid receptor agonists in a choice procedure in rats
- (2018) Vanessa Minervini et al. BEHAVIOURAL PHARMACOLOGY
- Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats
- (2017) E. Andrew Townsend et al. PSYCHOPHARMACOLOGY
- Insights from Preclinical Choice Models on Treating Drug Addiction
- (2017) Matthew L. Banks et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Shallow discounting of delayed cocaine by male rhesus monkeys when immediate food is the choice alternative.
- (2016) Sally L. Huskinson et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria
- (2016) Tarsis F. Brust et al. Science Signaling
- Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria
- (2016) Tarsis F. Brust et al. Science Signaling
- Increases in Drug and Opioid Overdose Deaths — United States, 2000–2014
- (2016) Rose A. Rudd et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Cocaine self-administration punished by intravenous histamine in adolescent and adult rats
- (2015) Nathan A. Holtz et al. BEHAVIOURAL PHARMACOLOGY
- Distinct Subpopulations of Nucleus Accumbens Dynorphin Neurons Drive Aversion and Reward
- (2015) Ream Al-Hasani et al. NEURON
- Abuse-deterrent formulations: Part 2: commercial products and proprietary technologies
- (2014) David J Mastropietro et al. EXPERT OPINION ON PHARMACOTHERAPY
- Assessment of the effects of contingent histamine injections on the reinforcing effectiveness of cocaine using behavioral economic and progressive-ratio designs
- (2014) Kevin B. Freeman et al. PSYCHOPHARMACOLOGY
- Assessment of the kappa opioid agonist, salvinorin A, as a punisher of drug self-administration in monkeys
- (2014) Kevin B. Freeman et al. PSYCHOPHARMACOLOGY
- Kappa Opioid Receptors on Dopaminergic Neurons Are Necessary for Kappa-Mediated Place Aversion
- (2013) Vladimir I Chefer et al. NEUROPSYCHOPHARMACOLOGY
- A single injection of a novel kappa opioid receptor agonist salvinorin A attenuates the expression of cocaine-induced behavioral sensitization in rats
- (2012) Aashish S. Morani et al. BEHAVIOURAL PHARMACOLOGY
- Dose-Related Behavioral, Subjective, Endocrine, and Psychophysiological Effects of the κ Opioid Agonist Salvinorin A in Humans
- (2012) Mohini Ranganathan et al. BIOLOGICAL PSYCHIATRY
- Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects
- (2012) Katherine A. MacLean et al. PSYCHOPHARMACOLOGY
- Suppression of cocaine self-administration in monkeys: effects of delayed punishment
- (2011) William L. Woolverton et al. PSYCHOPHARMACOLOGY
- The Therapeutic Potential of κ-Opioids for Treatment of Pain and Addiction
- (2010) Charles Chavkin NEUROPSYCHOPHARMACOLOGY
- The role of the dynorphin–κ opioid system in the reinforcing effects of drugs of abuse
- (2010) Sunmee Wee et al. PSYCHOPHARMACOLOGY
- Effect of kappa-opioid receptor agonists U69593, U50488H, spiradoline and salvinorin A on cocaine-induced drug-seeking in rats
- (2009) Aashish S. Morani et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Attenuation of cocaine-induced reinstatement of drug seeking in squirrel monkeys: kappa opioid and serotonergic mechanisms
- (2009) Daniela Rüedi-Bettschen et al. PSYCHOPHARMACOLOGY
- The Kappa-Opioid Agonist U69,593 Blocks Cocaine-Induced Enhancement of Brain Stimulation Reward
- (2008) Hilarie C. Tomasiewicz et al. BIOLOGICAL PSYCHIATRY
- Mu/kappa opioid interactions in rhesus monkeys: Implications for analgesia and abuse liability.
- (2008) S. Stevens Negus et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- Effects of Atypical -Opioid Receptor Agonists on Intrathecal Morphine-Induced Itch and Analgesia in Primates
- (2008) M.-C. Ko et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now